However, due to persistence of inflammatory activity, elevated C-reactive protein, thrombocytosis and progressive increase in aneurysm size, treatment was escalated to 5 sessions of plasmapheresis with controls after the last session where negative reactants were reported, as well as a decrease in the Z score size of reported aneurysms. The gene discussed is CRP; the disease is aneurysm.